Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


13th Tetrahedron Symposium (Asia) – Challenges in Bioorganic & Organic Medicinal Chemistry

27 Nov 2012 - 30 Nov 2012 - Taipei, Taiwan



Bookmark and Share


13th Tetrahedron Symposium (Asia) – Challenges in Bioorganic & Organic Medicinal Chemistry

27 - 30 November 2012, Taipei, Taiwan

 

Call for Abstracts! Deadline: 6 July 2012 – Click here

 

Chemistry is playing an increasingly pivotal role and chemists are often intimately involved at the forefront of the biological sciences whilst bringing to them the distinctive approaches of the rigorous chemical sciences.  The Symposium will also highlight the key role of chemistry in the discovery and development of new therapeutic agents for human diseases.

Lectures from a distinguished list of world-leading speakers will cover such topics as:

 

·         Sequencing nucleic acids: from chemistry to life sciences and medicine

·         Oligonucleotide-based tools for pharmacology and nano-engineering

·         The future of kinase drug discovery - challenges and opportunities

·         Vaccines as a new paradigm for the treatment of drug addiction

·         Fragment-based drug discovery: a decade of thinking small

·         Chemical biology of nanomedicines

·         Modulation of DNA damage-response pathways in cancer therapy

·         The chemical biology of protein splicing

·         Molecular design for selective recognition and reaction with RNA Target identification for biologically relevant small molecules

 

Speakers confirmed to date can be found here.

For more information visit: www.tetrahedronsymposiumasia.com

 



Further information
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
Crystal Clear Images Uncover Secrets of Hormone Receptors
NIH researchers gain better understanding of how neuropeptide hormones trigger chemical reactions in cells.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!